IL17A and Psoriasiform dermatitis: Additionally, interleukin-17 (IL-17) and interleukin-23 (IL-23), which are central to psoriasiform dermatitis by disrupting keratinocyte proliferation and barrier function, may also lead to the characteristic scaly plaques observed in affected patients [18], [19].